NEUROFIBROMATOSIS NETWORK (EIN 043030760) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

GREGG ERICKSON

Phone

6305101115

Tax Period

2022-10-01 to 2023-09-30

NEUROFIBROMATOSIS NETWORK, founded in 1990, is a small nonprofit in the Medical Research sector that reported $410K in total revenue in fiscal year 2022. Revenue fell 25% from the prior year — a significant decline worth monitoring. Expenses of $488K exceeded revenue, resulting in a 19% operating deficit.

Mission

TO PROVIDE INFORMATION ABOUT THE DISORDER NEUROFIBROMATOSIS TO THOSE AFFECTED AND HELP FAMILIES FIND MEDICAL, SOCIAL AND GENETIC COUNSELING. TO RAISE AND SEEK FUNDS FOR RESEARCH FOR A CURE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $365,293

Program Service Revenue $0

Investment Income $14,488

Other Revenue $30,602

TOTAL REVENUE $410,383

Expense Breakdown

Grants Paid $38,000

Salaries & Benefits $251,146

Fundraising Expenses $45,759

Program Expenses $414,256

Other Expenses $198,964

TOTAL EXPENSES $488,110

Year-over-Year Comparison

	2022	2021	Change
Revenue	$410,383	$548,640	-0.3%
Expenses	$488,110	$377,639	+0.3%
Net Income	$-77,727	$171,001	-1.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

120

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KIM BISCHOFF	EXECUTIVE DI	40.00	Highest	$104,158	$0	$104,158
ROSEMARY ANDERSON	BOARD MEMBER	5.00	Director	$0	$0	$0
DR FRANK BUONO	BOARD MEMBER	5.00	Director	$0	$0	$0
GREGG ERICKSON	TREASURER	15.00	Officer Director	$0	$0	$0
RYAN GEIER	VICE PRESIDE	15.00	Officer Director	$0	$0	$0
NICOLE HICKS	BOARD MEMBER	5.00	Director	$0	$0	$0
JUSTIN JORDAN	BOARD MEMBER	5.00	Director	$0	$0	$0
SHARON KLEIN	BOARD MEMBER	5.00	Director	$0	$0	$0
SHARON LOFTSPRING	SECRETARY	15.00	Officer Director	$0	$0	$0
PAUL MOOTS	BOARD MEMBER	5.00	Director	$0	$0	$0
JOHN MANTH	PRESIDENT	15.00	Officer Director	$0	$0	$0
MARIA POWELL	BOARD MEMBER	5.00	Director	$0	$0	$0
TERRI RAUSCH	BOARD MEMBER	5.00	Director	$0	$0	$0
ADAM ROSENBERG	BOARD MEMBER	5.00	Director	$0	$0	$0
MICHAEL SHEEDY	BOARD MEMBER	5.00	Director	$0	$0	$0
MICHELLE SLIMKO	BOARD MEMBER	5.00	Director	$0	$0	$0
SHANE SMITH	BOARD MEMBER	5.00	Director	$0	$0	$0
CHERI STEWART	BOARD MEMBER	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$410,383	$488,110	$1,185,451	$-77,727
2022	$548,640	$377,639	$1,209,936	$171,001
2021	$683,316	$315,772	$1,225,098	$367,544
2020	$346,583	$307,827	$771,011	$38,756
2019	$673,420	$329,499	$703,734	$343,921
2018	$453,800	$371,076	$417,083	$82,724

NEUROFIBROMATOSIS NETWORK